goto Index (07.05.03/07.29.05)
DrTim homepage link

HORMONES AND EPITHELIAL
OVARIAN CANCER
[in Menopause - Hormones and Cancer Proceedings]
edited by M. Neves -e-Castro and B.G. Wren 2002
[CH 15 p129-140]

Outline and Commentary on the 2002 Proceedings
by Timothy D. Bilash MD, MS, OBGYN
June 2003
www.DrTimDelivers.com

from
H.A. Risch [MHC CH 15]
Department of Epidemiology and Public Health
Yale University School of Medicine
60 College Street, P.O. Box 208034
New Haven, CT 06520-8034
USA

  1. Androgens

    1. plasma estrone is produced by adipose aromatization of androstenedione, about half of which is ovarian, and half adrenal in younger women
    2. Breast and ovarian epithelial cells express 17B-hydroxysteroid dehydrogenase (17BHSD), which converts Androstenedione to Testosterone (and Estrone to Estradiol)
    3. Androstenedione is a weak androgen, which does not bind strongly to Ar Androgen receptor
      1. converted in epithelial cells to testosterone, which does bind to Ar
    4. Plasma levels of androgens are greater than those of estrogens, even during the late follicular phase of the menstural cycle when estrogen levels are highest.
    5. Androgens may stimulate epithelial cell proliferation
      1. Testosterone stimulates ovarian epithelium
      2. epidemiology supports the association between androgens and risk of ovarian cancer


goto CH 1

goto Index

goto www.DrTimDelivers.com


page views since Sept2007